Mr. Sanjiv Navangul
With a passion for ‘Bringing Life to Life’, Bharat Serums and Vaccines Limited (BSV): A Mankind Group Company, is one of the leading and fastest-growing biopharmaceutical companies in India. Founded in 1971, BSV has a wide range of specialized biological, biotech and pharmaceutical products across Women’s Health (including IUI-IVF), Critical Care and Emergency Medicine.
Committed towards setting benchmarks in patient outcomes, research and innovation remains the strongest pillar in BSV’s journey. BSV is proud of its several first-of-its-kind indigenously developed specialized products that endeavour to address unmet medical needs. A dedicated team of 60+ scientists in the Research & Development centre in Mumbai work towards finding innovative treatments and cures, for millions of patients in India and across the globe.
BSV manufactures best-in-class quality products from its Good Manufacturing Practices (GMP) compliant facilities – one in Ambernath, Maharashtra India, and the other in Aachen, Germany. The US-FDA approved plant in Germany produces Active Pharmaceutical Ingredients (APIs) and formulations that cater to women’s health and critical care.
With a strong presence in India and over 70+ countries worldwide, BSV strives towards widening access and availability of products that help save and improve lives. BSV operates with three wholly owned subsidiaries in the Philippines, Germany and Malaysia.
Transparency, Agility, Accountability, and Collaboration form the pillars of BSV’s values-driven culture. Certified as a Great Place To Work® in India and Germany in 2024, BSV’s 2500+ employees work towards creating stakeholder value while making a sustainable impact on patient lives.
Driven by people and science, BSV remains committed to innovating in India, for India and the world.